Table II.
Functional and clinical outcome scores stratified by ADI subgroup.
| Overall N = 551 |
Group 1 N = 111 |
Group 2 N = 114 |
Group 3 N = 106 |
Group 4 N = 110 |
Group 5 N = 110 |
P value | |
|---|---|---|---|---|---|---|---|
| Preoperative ASES∗ | 30.6 (18.0) | 26.5 (15.3) | 33.2 (17.3) | 31.5 (19.5) | 35.1 (19.1) | 25.9 (16.7) | .009‡ |
| Preoperative Active Abduction∗ | 61 (30) | 62 (31) | 67 (32) | 56 (29) | 60 (29) | 60 (31) | .3 |
| Preoperative Active Forward Elevation∗ | 76 (36) | 75 (37) | 77 (34) | 76 (36) | 78 (38) | 74 (37) | >.9 |
| Preoperative Active External Rotation∗ | 17 (17) | 16 (17) | 15 (18) | 17 (16) | 15 (17) | 20 (19) | .2 |
| Postoperative Functional Scores, Range of Motion, and Patient Satisfaction | |||||||
| Postoperative ASES∗ | 74.2 (23.7) | 78.6 (21.6) | 75.8 (23.9) | 74.9 (23.4) | 71.4 (24.9) | 70.0 (24.1) | .047‡ |
| Postoperative Active Abduction∗ | 92 (19) | 92 (16) | 93 (17) | 94 (20) | 92 (22) | 90 (21) | .5 |
| Postoperative Active Forward Elevation∗ | 130 (31) | 135 (30) | 132 (31) | 128.0 (30) | 125 (34) | 129 (33) | .2 |
| Postoperative Active External Rotation∗ | 32 (15) | 33 (15) | 33 (18) | 33 (15) | 30 (14) | 31 (14) | .3 |
| Patient Satisfaction† | .3 | ||||||
| Much better | 378 (68.6%) | 86 (77.5%) | 78 (68.4%) | 77 (72.6%) | 67 (60.9%) | 70 (63.6%) | |
| Better | 121 (22.0%) | 18 (16.2%) | 25 (21.9%) | 18 (17.0%) | 31 (28.2%) | 29 (26.4%) | |
| Unchanged | 26 (4.7%) | 4 (3.6%) | 7 (6.1%) | 3 (2.8%) | 6 (5.5%) | 6 (5.5%) | |
| Worse | 26 (4.7%) | 3 (2.7%) | 4 (3.5%) | 8 (7.5%) | 6 (5.5%) | 5 (4.5%) | |
| Δ Difference | |||||||
| ASES Difference∗ | 42.8 (26.2) | 48.6 (25.3) | 42.0 (26.1) | 44.3 (22.5) | 36.5 (29.1) | 43.1 (26.8) | .2 |
| Patient-Reported Outcome Measures | |||||||
| MCID ASES† | 483 (87.6%) | 102 (90.9%) | 104 (91.4%) | 94 (88.7%) | 88 (79.7%) | 95 (86.7%) | .2 |
| SCB ASES† | 380 (68.9%) | 86 (77.3%) | 78 (68.6%) | 70 (66.1%) | 69 (62.5%) | 77 (70.0%) | .5 |
| PASS ASES† | 317 (57.5%) | 64 (57.4%) | 76 (66.7%) | 55 (51.6%) | 57 (51.5%) | 51 (46.2%) | .14 |
| Adverse Outcomes | |||||||
| Adverse Event† | 54 (9.8%) | 13 (11.7%) | 10 (8.8%) | 6 (5.7%) | 14 (12.7%) | 11 (10.0%) | .4 |
| Revision Rate† | 36 (6.5%) | 10 (9.0%) | 10 (8.8%) | 1 (0.9%) | 9 (8.2%) | 6 (5.5%) | .085 |
ADI, Area Deprivation Index; ASES, American Shoulder and Elbow Surgeons; MCID, minimal clinically important difference; PASS, patient acceptable symptomatic state; SCB, substantial clinical benefit.
∗
Mean (Standard Deviation).
†
Number of patients n (%).
‡
Statistically significant P < .05.